Abstract
Purpose
This study explores the source(s) of the matrix-degrading proteinases, matrix metalloproteinase 1 (MMP-1; interstitial collagenase), matrix metalloproteinase 3 (MMP-3; stromelysin 1), and matrix metalloproteinase 9 (MMP-9; gelatinase B), previously implicated in abdominal aortic aneurysm (AAA) development. The possible involvement of the plasmin cascade in the activation of these proteinases was also explored by examining the presence of the urokinase-type plasminogen activator (uPA) in aneurysm wall.Methods
Immunohistochemical techniques were used to detect the presence of MMP-1, MMP-3 and MMP-9 proteins and uPA in fixed, paraffin-embedded tissue sections from AAA (n = 10) and control (n = 2) aortas.Results
The MMP-9 protein was localized to mononuclear cells in the AAA wall. Dual-labeling techniques confirmed the identity of these cells as macrophages. The MMP-3 protein and uPA were also detected primarily in the macrophage-like mononuclear cells infiltrating the aneurysmal aorta. Immunoreactive material to MMP-1 was demonstrated in mesenchymal cells of the AAA wall suggesting alternative expression and delivery of this enzyme in AAA.Conclusions
This work establishes the role of macrophages in the delivery, expression, and possible activation of matrix destructive proteinases during AAA pathogenesis and suggests a role for the activation of MMPs in the progression of the disease.Full text links
Read article at publisher's site: https://doi.org/10.1016/s0741-5214(94)70169-5
Read article for free, from open access legal sources, via Unpaywall: http://www.jvascsurg.org/article/S0741521494701695/pdf
Citations & impact
Impact metrics
Article citations
Evidence Accumulates: Patients with Ascending Aneurysms Are Strongly Protected from Atherosclerotic Disease.
Int J Mol Sci, 24(21):15640, 27 Oct 2023
Cited by: 2 articles | PMID: 37958625 | PMCID: PMC10650782
Review Free full text in Europe PMC
Extracellular Matrix Remodeling in Vascular Disease: Defining Its Regulators and Pathological Influence.
Arterioscler Thromb Vasc Biol, 43(9):1599-1616, 06 Jul 2023
Cited by: 10 articles | PMID: 37409533 | PMCID: PMC10527588
Review Free full text in Europe PMC
Matrix Metalloproteinase-2 and -3 Levels in Patients with Behçet's Disease and Implication for the Presence of Vascular Aneurysm or Neurologic Involvement.
Eur J Rheumatol, 10(3):101-106, 01 Jul 2023
Cited by: 0 articles | PMID: 37681256 | PMCID: PMC10543994
Molecular and Cellular Mechanisms Involved in Aortic Wall Aneurysm Development.
Diagnostics (Basel), 13(2):253, 10 Jan 2023
Cited by: 6 articles | PMID: 36673063 | PMCID: PMC9858209
Review Free full text in Europe PMC
A New Twist in the Abdominal Aortic Aneurysm Story.
Aorta (Stamford), 9(4):167-168, 01 Aug 2021
Cited by: 0 articles | PMID: 34715700 | PMCID: PMC8642074
Go to all (118) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Matrix metalloproteinase expressions in arteriosclerotic aneurysmal disease.
Vasc Endovascular Surg, 36(1):1-7, 01 Jan 2002
Cited by: 15 articles | PMID: 12704518
Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources.
Connect Tissue Res, 30(4):265-276, 01 Jan 1994
Cited by: 99 articles | PMID: 7956205
Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm.
Arterioscler Thromb Vasc Biol, 25(7):1341-1346, 21 Apr 2005
Cited by: 48 articles | PMID: 15845912
Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic target.
J Clin Pharmacol, 38(12):1077-1088, 01 Dec 1998
Cited by: 19 articles | PMID: 11301559
Review
Funding
Funders who supported this work.
NHLBI NIH HHS (1)
Grant ID: HL29325
NIAMS NIH HHS (1)
Grant ID: AR39189